DocNexus is hosting an upcoming webinar titled KOL Identification & Segmentation in Breast Cancer on September 10, 2026, at 9:00 AM PT.
Public source
Publisher name
Public post
Just a week away for DocNexus' upcoming webinar: "KOL Identification & Segmentation in Breast Cancer" Join us on September 10 for a focused discussion on using data-driv…
Company
DocNexus
Unifying global healthcare data into decision-grade intelligence for life sciences teams.
- Industry
- Software Development
- Location
- Seattle, US
- Company size
- 11–50 employees
About DocNexus
DocNexus is an AI-powered commercial real-world data platform that unifies healthcare’s most fragmented data including claims, prescriptions, procedures, referrals, HCP and HCO identities, publications, clinical trials, payments, social signals, and news into decision-ready knowledge graphs for life sciences teams. We help pharmaceutical and biotech companies accelerate research, strengthen competitive intelligence, and make higher-quality strategic decisions with speed and confidence. With coverage spanning 12M+ HCPs and KOLs, 595k+ HCOs, 350M+ patients, and billions of medical, scientific, and digital signals, DocNexus provides a single, comprehensive view of the healthcare ecosystem, continuously refreshed and instantly searchable. Core capabilities include: 🔵KOL and HCP discovery across 36 therapeutic areas using ranking signals from publications, trials, procedures, payments, referrals, and digital influence 🔵Influence and collaboration mapping powered by AI-generated knowledge graphs 🔵Commercial real-world data analytics for opportunity sizing, targeting, and competitive benchmarking 🔵Payer mix, reimbursement, and access insights to support market access strategy 🔵Advanced HCO and IDN search for site selection, procedure density, and health system mapping 🔵AI-powered search across healthcare real-world data that delivers instant, contextual insights to support fast, evidence-based decisions, Life sciences teams use DocNexus to: 🔵Identify KOLs and assemble advisory boards in days instead of weeks 🔵Select high-performing investigators and clinical trial sites with evidence-based precision 🔵Target the right HCOs, IDNs, and referral hubs for commercial strategy 🔵Monitor competitors and emerging scientific leaders in real time 🔵Centralize insights, dashboards, lists, and workflows across medical, commercial, and market access teams
See moreLatest activity
Latest activity from DocNexus
7 signals
Presence & Recognition
DocNexus is hosting an upcoming webinar titled KOL Identification and Segmentation in Breast Cancer on September 10, 2026, at 9:00 AM PT.
Presence & Recognition
DocNexus announced that Jennifer Whipkey, Associate Vice President, Marketing at Menarini Stemline, will be speaking at the DocNexus AI Summit 2026 in Philadelphia on September 18.
Presence & Recognition
DocNexus is attending the Alternative Data Conference New York 2026 at the E2 in the Explorer Hub at Ease Hospitality on September 10, 2026.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
PatientPoint®
PatientPoint® is hosting a webinar for oncology brand marketers on Tuesday, September 8, 2026, featuring Douglas Flora, MD, LSSBB, Nicole Chambers, MBA, and Linda Ruschau
Presence & Recognition
BenchSci
BenchSci is hosting a webinar titled Sean Holloran, PhD, running a real drug safety investigation from start to finish using FDA adverse event data, drug interaction risk, and peer-reviewed literature.
Presence & Recognition
RxLogix Corporation
RxLogix Corporation is hosting a live webinar on September 16 to discuss how RxLogix PV Reports and PV Analytics help life sciences organizations reduce manual effort by 80%, accelerate reporting by up to 60%, and gain faster visibility into strategic insights.
Presence & Recognition
Opmed.ai
Opmed.ai is hosting a 30-minute webinar on September 15 at 12:00 PM ET titled Rethinking Procedure Scheduling with AI to explore how improved prediction accuracy reduces scheduling risk, limits daily disruption, and improves OR operations.
Presence & Recognition
Mayden